BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 03/06/2003

Ophthalmic Drug Products for Over-the-Counter Human Use; Final Monograph; Technical Amendment

The Food and Drug Administration (FDA) is amending the regulation that established conditions under which over-the-counter (OTC) ophthalmic drug products are generally recognized as safe and effective and not misbranded. This amendment updates the monograph to incorporate a United States Pharmacopeia (USP) name change for one active ingredient included in the monograph. This final rule is part of FDA's ongoing review of OTC drug products.

Source: Federal Register — Food and Drug AdministrationOpen original release →